These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 18959065)

  • 1. [Quality control in transfusion activity--legal regulations].
    Dorotea S
    Lijec Vjesn; 2007 May; 129 Suppl 3():45-6. PubMed ID: 18959065
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality assurance programmes in transfusion serology.
    Beal RW
    Malays J Pathol; 1987 Aug; 9():23-5. PubMed ID: 3452708
    [No Abstract]   [Full Text] [Related]  

  • 3. [Expectations on the guideline for blood transfusion. 2].
    Yasuda J
    Rinsho Byori; 1991 Mar; Suppl 88():317-20. PubMed ID: 1856986
    [No Abstract]   [Full Text] [Related]  

  • 4. [Consensus and non-consensus on portions of the blood transfusion policy].
    van Aken WG
    Ned Tijdschr Geneeskd; 1983 Oct; 127(40):1818-21. PubMed ID: 6633731
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trends and new directions in transfusion medicine].
    Biscoping J; Götz E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):661. PubMed ID: 9825051
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality improvement opportunities in blood banking and transfusion medicine.
    Brooks JP
    Clin Lab Med; 2008 Jun; 28(2):321-37, viii. PubMed ID: 18436074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I minimize mistransfusion risk in my hospital.
    Aubuchon JP
    Transfusion; 2006 Jul; 46(7):1085-9. PubMed ID: 16836553
    [No Abstract]   [Full Text] [Related]  

  • 8. [Understanding the role of the European public institutions in blood transfusion].
    Behr-Gross ME
    Transfus Clin Biol; 2009 May; 16(2):237-40. PubMed ID: 19443256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Work organisation improvement methods applied to activities of Blood Transfusion Establishments (BTE): Lean Manufacturing, VSM, 5S].
    Bertholey F; Bourniquel P; Rivery E; Coudurier N; Follea G
    Transfus Clin Biol; 2009 May; 16(2):93-100. PubMed ID: 19446483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality of transfusion means and protocols of massive transfusions].
    Zhiburt EB; Vergopulo AA; Kopchenko TG; Gubanova MN
    Vestn Khir Im I I Grek; 2009; 168(2):75-7. PubMed ID: 19514398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autologous transfusion -- from euphoria to reason: clinical practice based on scientific knowledge (Part II). Amendment to the transfusion act: easing of legal provisions on salvaged blood preparations].
    Auer F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Nov; 39(11):685-6. PubMed ID: 15523584
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quality control in Blood Transfusion Centers in 1993].
    Mannessier L; Krause C
    Transfus Clin Biol; 1994; 1(4):303-4. PubMed ID: 7921286
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some considerations on "regulation, practices and public health stakes" in blood transfusion].
    Marimbert J
    Transfus Clin Biol; 2009 May; 16(2):170-1. PubMed ID: 19442551
    [No Abstract]   [Full Text] [Related]  

  • 14. [Responsibility and consent of patients in transfusion medicine: social responsibility of the recipient and donor for quality of care].
    Mesarić J; Minigo H
    Lijec Vjesn; 2007 May; 129 Suppl 3():50. PubMed ID: 18959069
    [No Abstract]   [Full Text] [Related]  

  • 15. Proteomics and transfusion medicine.
    Zolla L
    Blood Transfus; 2008 Apr; 6(2):67-9. PubMed ID: 18946950
    [No Abstract]   [Full Text] [Related]  

  • 16. [INTS: formation and political quality].
    Rouger P
    Transfus Clin Biol; 2007 Oct; 14(4):419. PubMed ID: 17921000
    [No Abstract]   [Full Text] [Related]  

  • 17. [Practical examples in connection with the legal regulations of human blood donors].
    HAASE H
    Bibl Haematol; 1959; 9():198-204. PubMed ID: 13651091
    [No Abstract]   [Full Text] [Related]  

  • 18. Current risks in blood transfusion in Japan.
    Otsubo H; Yamaguchi K
    Jpn J Infect Dis; 2008 Nov; 61(6):427-33. PubMed ID: 19050347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guidelines of the German Medical Association for Therapy with Blood Components and Plasma Derivatives--an introduction. Evidence-based recommendations for the risk-benefit analysis in hemotherapy].
    Heim MU
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):186-97; quiz 199. PubMed ID: 19266420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparing for inspection: managing regulations and practices surrounding donors with positive infectious disease testing.
    Ferschke J
    J Clin Apher; 2008; 23(6):191-5. PubMed ID: 18973114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.